This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L02BB
1 out of 7 registries used, show all original rules.
2859
Check minimum number of events
Min. number of events
3
2859
Include endpoints None
2859
Remove individuals based on genotype QC
2748
RX_L02BB
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF3
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
L02BB Anti-androgens
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2748 | - | 2747 |
| Unadjusted prevalence (%) | 0.67 | - | 1.51 |
| Mean age at first event (years) | 71.55 | - | 71.56 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_L02BB – L02BB Anti-androgens
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after L02BB Anti-androgens
↥Endpoint not on priority list, no data to show.